Asset Allocation

As of September 30, 2025.
Type % Net
Cash 0.14%
Stock 79.48%
Bond 7.84%
Convertible 0.00%
Preferred 0.20%
Other 12.34%
View Asset Allocation
Start Trial

Market Capitalization

As of September 30, 2025
Large 84.34%
Mid 11.10%
Small 4.56%
View Market Capitalization
Start Trial

Region Exposure

% Developed Markets: 85.07%    % Emerging Markets: 1.11%    % Unidentified Markets: 13.82%

Americas 29.06%
28.73%
Canada 2.55%
United States 26.17%
0.34%
Mexico 0.19%
As of September 30, 2025. Region breakdown data is calculated by using the long position holdings of the portfolio.
Greater Europe 47.36%
United Kingdom 11.32%
35.31%
France 13.79%
Germany 3.32%
Ireland 2.76%
Italy 5.20%
Netherlands 5.64%
Spain 2.67%
Switzerland 1.86%
0.52%
Turkey 0.52%
0.21%
Israel 0.11%
Nigeria 0.03%
United Arab Emirates 0.04%
Greater Asia 9.75%
Japan 0.00%
1.11%
Australia 1.11%
8.41%
Hong Kong 0.74%
Singapore 1.07%
South Korea 2.35%
Taiwan 4.26%
0.23%
India 0.18%
Unidentified Region 13.82%

Bond Credit Quality Exposure

AAA --
AA --
A --
BBB --
BB --
B --
Below B --
    CCC --
    CC --
    C --
    DDD --
    DD --
    D --
Not Rated --
Not Available --
Short Term --
No Data Available
View Bond Credit Quality Exposure
Start Trial

Stock Sector Exposure

Cyclical
25.85%
Materials
2.07%
Consumer Discretionary
1.74%
Financials
21.88%
Real Estate
0.17%
Sensitive
43.54%
Communication Services
19.23%
Energy
6.99%
Industrials
4.48%
Information Technology
12.83%
Defensive
17.50%
Consumer Staples
3.48%
Health Care
6.42%
Utilities
7.60%
Not Classified
13.11%
Non Classified Equity
0.10%
Not Classified - Non Equity
13.01%
As of September 30, 2025
View Region Exposure
Start Trial

Bond Sector Exposure

As of September 30, 2025
Type % Net
Government 4.41%
Corporate 56.57%
Securitized 36.01%
Municipal 0.00%
Other 3.01%
View Bond Sector Exposure
Start Trial

Bond Maturity Exposure

Short Term --
Less than 1 Year --
Intermediate --
1 to 3 Years --
3 to 5 Years --
5 to 10 Years --
Long Term --
10 to 20 Years --
20 to 30 Years --
Over 30 Years --
Other --
No Data Available
View Bond Maturity Exposure
Start Trial